Milrinone Lactate (CAS 100286-97-3): Your Premier Pharmaceutical Intermediate
Discover the critical role of Milrinone Lactate in advanced pharmaceutical synthesis. As a leading supplier in China, we offer high-purity intermediates essential for developing life-saving cardiac treatments and innovative APIs.
Get a Quote & SampleProduct Core Value
Milrinone Lactate
Milrinone Lactate is a vital pharmaceutical intermediate, recognized for its potent phosphodiesterase III inhibitory and inodilator properties. It serves as a cornerstone in the synthesis of APIs for cardiovascular therapies, particularly for managing acute decompensated heart failure. We are a reliable supplier in China, dedicated to providing high-quality intermediates that meet stringent industry standards for drug synthesis.
- Explore the precise applications of Milrinone lactate pharmaceutical intermediate in the development of novel cardiac drugs.
- Benefit from our expertise in CAS 100286-97-3 drug synthesis, ensuring consistent product quality and yield.
- Understand the manufacturing processes involved in Phosphodiesterase III inhibitor production with our detailed product insights.
- Secure your supply of this essential Inodilator API production ingredient from a trusted manufacturer in China.
Key Advantages
High Purity for Reliable Synthesis
Our Milrinone Lactate offers exceptional purity, crucial for complex drug synthesis and ensuring the efficacy and safety of the final pharmaceutical product. This commitment to quality supports robust API production.
Expertise in Pharmaceutical Intermediates
Leverage our deep understanding of CAS 100286-97-3 drug synthesis. We provide technical support and high-quality materials, making us a preferred Milrinone lactate supplier in China for global pharmaceutical companies.
Critical for Cardiovascular Therapies
As a key building block for inotropic agents and vasodilators, Milrinone Lactate is indispensable for developing treatments for heart failure, underscoring its importance in medical advancements.
Key Applications
Cardiotonic Drug Development
Used in the synthesis of cardiotonic agents that enhance heart muscle contraction, crucial for treating severe heart conditions. This aligns with current research in cardiac drug synthesis.
Heart Failure Treatment APIs
Essential intermediate for manufacturing Active Pharmaceutical Ingredients (APIs) used in short-term intravenous treatment of acute decompensated heart failure, directly impacting patient outcomes.
Phosphodiesterase III Inhibitors
A critical component in the production of selective PDE III inhibitors, which play a vital role in vasodilation and improving cardiac function. This is key for Phosphodiesterase III inhibitor manufacturing.
Pharmaceutical Research & Development
Supports ongoing R&D in cardiovascular pharmacology, providing a reliable starting material for exploring new therapeutic applications and improving existing treatments.